KalVista Pharmaceuticals, Inc.KALVNASDAQ
Loading
Capital Expenditure Over TimeExpanding
Percentile Rank62
Studio
Year-over-Year Change

Cash spent on acquiring or upgrading physical assets

Latest
$-91000.00
↑ 85% vs avg
Percentile
P62
Within normal range
Streak
3 yr
Consecutive growthExpanding
Average
$-597900.00
Historical baseline
PeriodValueYoY Change
TTM$-91000.00+79.0%
2025$-434000.00+2.0%
2024$-443000.00+63.0%
2023$-1.20M-28.5%
2022$-931000.00-1035.4%
2021$-82000.00+62.7%
2020$-220000.00+79.6%
2019$-1.08M+24.2%
2018$-1.43M-1828.4%
2017$-74000.00-